Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HKSE:02211's Return-on-Tangible-Equity is ranked worse than 79.9% of 592
companies
in the Healthcare Providers & Services industry
Industry Median: 10.72
vs HKSE:02211: -7.30
Universal Health International Group Holding (HKSE:02211) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Universal Health International Group Holding Return-on-Tangible-Equity Related Terms
Universal Health International Group Holding Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Universal Health International Group Holding Return-on-Tangible-Equity Chart
Universal Health International Group Holding Annual Data
Universal Health International Group Holding Return-on-Tangible-Equity Competitor Comparison
For the Pharmaceutical Retailers subindustry, Universal Health International Group Holding's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Universal Health International Group Holding Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Universal Health International Group Holding's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Universal Health International Group Holding's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of -3.64% mean?
Universal Health International Group Holding (HKSE:02211) has a Return-on-Tangible-Equity of -3.64% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Universal Health International Group Holding and its competitors. According to the industry distribution chart, Universal Health International Group Holding ranks #473 out of 592 companies in the Healthcare Providers & Services industry, placing it in the top 79.9%.
Is Universal Health International Group Holding's Return-on-Tangible-Equity too high?
Universal Health International Group Holding's current Return-on-Tangible-Equity is -3.64%. Based on the distribution chart, Universal Health International Group Holding ranks #473 out of 592 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Universal Health International Group Holding has a GF Score™ of 37/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Universal Health International Group Holding's Return-on-Tangible-Equity compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Universal Health International Group Holding ranks #473 out of 592 companies for Return-on-Tangible-Equity. This places Universal Health International Group Holding in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.72, based on 592 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Universal Health International Group Holding and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Universal Health International Group Holding's current Return-on-Tangible-Equity is -3.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universal Health International Group Holding stock overvalued right now?
Based on GuruFocus' analysis, Universal Health International Group Holding (HKSE:02211) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.29, compared to a current price of HK$0.66 — trading 125.9% above its estimated fair value. The current Return-on-Tangible-Equity is -3.64%. Universal Health International Group Holding's overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Universal Health International Group Holding (HKSE:02211), the current Return-on-Tangible-Equity is -3.64% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Universal Health International Group Holding (HKSE:02211) Overvalued in 2026?
Based on GuruFocus' analysis, Universal Health International Group Holding stock appears to be overvalued.
The current stock price of HK$0.66 is trading 125.9% above its estimated GF Value™ of HK$0.29.
GuruFocus considers Universal Health International Group Holding to be Significantly Overvalued.
Key valuation signals for HKSE:02211:
Return-on-Tangible-Equity: -3.64%
GF Value™: HK$0.29 vs. price of HK$0.66 (125.9% above fair value)
No single metric tells the full story. See the HKSE:02211 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Universal Health International Group Holding Ltd distributes and retails pharmaceutical products in Northeast China. The company operates its business through two segments: pharmaceutical retail and Distribution, (including import and export trade) include prescribed drugs, non-prescribed drugs (Chinese patent medicines, chemical preparations, antibiotics and biochemical drugs), traditional Chinese medicine decoction pieces, biological products, protein assimilation preparations, peptide hormones, blood products, disinfection products, medical equipment, etc. and majority of revnue comes from Distribution segment.
37GF Score
Get the complete analysis for HKSE:02211
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02211 has been successfully added to your 
